Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9059)
All Articles published online
|
Publishing Process of This Article
|
Apr 26, 2014 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Stem Cells
ISSN
1948-0210
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Bayin NS, Modrek AS, Placantonakis DG. Glioblastoma stem cells: Molecular characteristics and therapeutic implications. World J Stem Cells 2014; 6(2): 230-238 [PMID: 24772249 DOI: 10.4252/wjsc.v6.i2.230] |
|---|---|
| URL: | https://www.wjgnet.com/1948-0210/full/v6/i2/230.htm |
| Number | Citing Articles |
| 1 |
Julia Langhans, Lukas Schneele, Nancy Trenkler, Hélène von Bandemer, Lisa Nonnenmacher, Georg Karpel-Massler, Markus D. Siegelin, Shaoxia Zhou, Marc-Eric Halatsch, Klaus-Michael Debatin, Mike-Andrew Westhoff. The effects of PI3K-mediated signalling on glioblastoma cell behaviour. Oncogenesis 2017; 6(11) doi: 10.1038/s41389-017-0004-8
|
| 2 |
Chiara Pesenti, Stefania Elena Navone, Laura Guarnaccia, Andrea Terrasi, Jole Costanza, Rosamaria Silipigni, Silvana Guarneri, Nicola Fusco, Laura Fontana, Marco Locatelli, Paolo Rampini, Rolando Campanella, Silvia Tabano, Monica Miozzo, Giovanni Marfia. The Genetic Landscape of Human Glioblastoma and Matched Primary Cancer Stem Cells Reveals Intratumour Similarity and Intertumour Heterogeneity. Stem Cells International 2019; 2019: 1 doi: 10.1155/2019/2617030
|
| 3 |
Michiya Sugimori, Yumiko Hayakawa, Ryoi Tamura, Satoshi Kuroda. The combined efficacy of OTS964 and temozolomide for reducing the size of power-law coded heterogeneous glioma stem cell populations. Oncotarget 2019; 10(24): 2397 doi: 10.18632/oncotarget.26800
|
| 4 |
Julio Inocencio, Joshua D. Frenster, Dimitris G. Placantonakis. Glioblastoma. Methods in Molecular Biology 2018; 1741: 71 doi: 10.1007/978-1-4939-7659-1_5
|
| 5 |
Shuxia Zhang, Yeru Chen, Yongjie Wang, Piao Zhang, Gang Chen, Youfa Zhou. Insights Into Translatomics in the Nervous System. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.599548
|
| 6 |
N S Bayin, J D Frenster, J R Kane, J Rubenstein, A S Modrek, R Baitalmal, I Dolgalev, K Rudzenski, L Scarabottolo, D Crespi, L Redaelli, M Snuderl, J G Golfinos, W Doyle, D Pacione, E C Parker, A S Chi, A Heguy, D J MacNeil, N Shohdy, D Zagzag, D G Placantonakis. GPR133 (ADGRD1), an adhesion G-protein-coupled receptor, is necessary for glioblastoma growth. Oncogenesis 2016; 5(10): e263 doi: 10.1038/oncsis.2016.63
|
| 7 |
Weichen Duan, Miao Yu, Jiajia Chen. BRD4: New hope in the battle against glioblastoma. Pharmacological Research 2023; 191: 106767 doi: 10.1016/j.phrs.2023.106767
|
| 8 |
Fabien Almairac, Laurent Turchi, Nathalie Sakakini, David Nicolas Debruyne, Sarah Elkeurti, Elisabet Gjernes, Beatrice Polo, Laurence Bianchini, Denys Fontaine, Philippe Paquis, Herve Chneiweiss, Marie-Pierre Junier, Patrick Verrando, Fanny Burel-Vandenbos, Thierry Virolle. ERK-Mediated Loss of miR-199a-3p and Induction of EGR1 Act as a “Toggle Switch” of GBM Cell Dedifferentiation into NANOG- and OCT4-Positive Cells. Cancer Research 2020; 80(16): 3236 doi: 10.1158/0008-5472.CAN-19-0855
|
| 9 |
Nikole Gontijo Gonçales, Bryan Ôrtero Perez Gonçalves, Luciana Maria Silva, Agnaldo Lopes da Silva Filho, Letícia da Conceição Braga. TNFRSF10D expression as a potential biomarker for cisplatin-induced damage and ovarian tumor relapse prediction. Pathology - Research and Practice 2024; 263: 155592 doi: 10.1016/j.prp.2024.155592
|
| 10 |
Huaming Yan, Monica Romero-Lopez, H.B. Frieboes, C.C.W. Hughes, J.S. Lowengrub. Multiscale Modeling of Glioblastoma Suggests that the Partial Disruption of Vessel/Cancer Stem Cell Crosstalk Can Promote Tumor Regression without Increasing Invasiveness. IEEE Transactions on Biomedical Engineering 2016; : 1 doi: 10.1109/TBME.2016.2615566
|
| 11 |
Matthew Gallitto, Stanislav Lazarev, Isaac Wasserman, James M. Stafford, Suzanne L. Wolden, Stephanie A. Terezakis, Ranjit S. Bindra, Richard L. Bakst. Role of Radiation Therapy in the Management of Diffuse Intrinsic Pontine Glioma: A Systematic Review. Advances in Radiation Oncology 2019; 4(3): 520 doi: 10.1016/j.adro.2019.03.009
|
| 12 |
Sevgi Irtegun Kandemir, Polat Ipek. Antiproliferative effect of Potentilla fulgens on glioblastoma cancer cells through downregulation of Akt/mTOR signaling pathway. Journal of Cancer Research and Therapeutics 2023; 19(7): 1818 doi: 10.4103/jcrt.jcrt_1886_21
|
| 13 |
Marcin Teodorczyk, Mirko H. H. Schmidt. Notching on Cancer’s Door: Notch Signaling in Brain Tumors. Frontiers in Oncology 2015; 4 doi: 10.3389/fonc.2014.00341
|
| 14 |
Eno I. Essien, Thomas P. Hofer, Michael J. Atkinson, Nataša Anastasov. Combining HDAC and MEK Inhibitors with Radiation against Glioblastoma-Derived Spheres. Cells 2022; 11(5): 775 doi: 10.3390/cells11050775
|
| 15 |
M.-A. Jourdain, J. Eyer. Recent advances in liposomes and peptide-based therapeutics for glioblastoma treatment. Journal of Controlled Release 2024; 376: 732 doi: 10.1016/j.jconrel.2024.10.037
|
| 16 |
Kaya E. Witte, Oliver Hertel, Beatrice A. Windmöller, Laureen P. Helweg, Anna L. Höving, Cornelius Knabbe, Tobias Busche, Johannes F. W. Greiner, Jörn Kalinowski, Thomas Noll, Fritz Mertzlufft, Morris Beshay, Jesco Pfitzenmaier, Barbara Kaltschmidt, Christian Kaltschmidt, Constanze Banz-Jansen, Matthias Simon. Nanopore Sequencing Reveals Global Transcriptome Signatures of Mitochondrial and Ribosomal Gene Expressions in Various Human Cancer Stem-like Cell Populations. Cancers 2021; 13(5): 1136 doi: 10.3390/cancers13051136
|
| 17 |
Rasime Kalkan. Glioblastoma Stem Cells as a New Therapeutic Target for Glioblastoma. Clinical Medicine Insights: Oncology 2015; 9 doi: 10.4137/CMO.S30271
|
| 18 |
Silvana Valdebenito, Daniela D'Amico, Eliseo Eugenin. Novel approaches for glioblastoma treatment: Focus on tumor heterogeneity, treatment resistance, and computational tools. Cancer Reports 2019; 2(6) doi: 10.1002/cnr2.1220
|
| 19 |
Chiao-Pei Cheng, Li-Chun Huang, Yung-Lung Chang, Ching-Hsuan Hsieh, Shih-Ming Huang, Dueng-Yuan Hueng. The mechanisms of malic enzyme 2 in the tumorigenesis of human gliomas. Oncotarget 2106; 7(27): 41460 doi: 10.18632/oncotarget.9190
|
| 20 |
Kalina Tumangelova-Yuzeir, Emanuil Naydenov, Ekaterina Ivanova-Todorova, Ekaterina Krasimirova, Georgi Vasilev, Sevdalin Nachev, Dobroslav Kyurkchiev. Mesenchymal Stem Cells Derived and Cultured from Glioblastoma Multiforme Increase Tregs, Downregulate Th17, and Induce the Tolerogenic Phenotype of Monocyte-Derived Cells. Stem Cells International 2019; 2019: 1 doi: 10.1155/2019/6904638
|
| 21 |
Ryota Tamura, Hiroyuki Miyoshi, Yukina Morimoto, Yumiko Oishi, Oltea Sampetrean, Chizuru Iwasawa, Yutaka Mine, Hideyuki Saya, Kazunari Yoshida, Hideyuki Okano, Masahiro Toda. Gene Therapy Using Neural Stem/Progenitor Cells Derived from Human Induced Pluripotent Stem Cells: Visualization of Migration and Bystander Killing Effect. Human Gene Therapy 2020; 31(5-6): 352 doi: 10.1089/hum.2019.326
|
| 22 |
Jee-Wei Emily Chen, Sarah Leary, Victoria Barnhouse, Jann N. Sarkaria, Brendan A.C. Harley. Matrix Hyaluronic Acid and Hypoxia Influence a CD133+ Subset of Patient-Derived Glioblastoma Cells. Tissue Engineering Part A 2022; 28(7-8): 330 doi: 10.1089/ten.tea.2021.0117
|
| 23 |
Sunita Jhulki, Aparajita Pal. Exploring the Potential of Phytochemicals Derived From Indian Medicinal Plants for Management and Treatment of Glioblastoma Multiforme Based on In Vitro Studies. Journal of Herbal Medicine 2024; 44: 100856 doi: 10.1016/j.hermed.2024.100856
|
| 24 |
Rolando Campanella, Laura Guarnaccia, Manuela Caroli, Barbara Zarino, Giorgio Carrabba, Nicla La Verde, Chiara Gaudino, Angela Rampini, Sabino Luzzi, Laura Riboni, Marco Locatelli, Stefania Elena Navone, Giovanni Marfia. Personalized and translational approach for malignant brain tumors in the era of precision medicine: the strategic contribution of an experienced neurosurgery laboratory in a modern neurosurgery and neuro-oncology department. Journal of the Neurological Sciences 2020; 417: 117083 doi: 10.1016/j.jns.2020.117083
|
| 25 |
Philippe Aretz, Donata Maciaczyk, Suad Yusuf, Rüdiger V. Sorg, Daniel Hänggi, Hongjia Liu, Hongde Liu, Tikam Chand Dakal, Amit Sharma, Ramakrishna Bethanabatla, Silke Neumann, Jarek Maciaczyk. Crosstalk between β-Catenin and CCL2 Drives Migration of Monocytes towards Glioblastoma Cells. International Journal of Molecular Sciences 2022; 23(9): 4562 doi: 10.3390/ijms23094562
|
| 26 |
Mariangela Sottili, Chiara Gerini, Isacco Desideri, Mauro Loi, Lorenzo Livi, Monica Mangoni. Radiobiology of Glioblastoma. Current Clinical Pathology 2016; : 189 doi: 10.1007/978-3-319-28305-0_12
|
| 27 |
Jiri Sana, Petr Busek, Pavel Fadrus, Andrej Besse, Lenka Radova, Marek Vecera, Stefan Reguli, Lucie Stollinova Sromova, Marek Hilser, Radim Lipina, Radek Lakomy, Leos Kren, Martin Smrcka, Aleksi Sedo, Ondrej Slaby. Identification of microRNAs differentially expressed in glioblastoma stem-like cells and their association with patient survival. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-20929-6
|
| 28 |
Jun Young Park, Ye Lim Cho, Tae Sup Lee, Daekyun Lee, Ju-Hyung Kang, Soryong Lim, Yujin Lee, Jae Hyun Lim, Won Jun Kang. In Vivo Evaluation of 68Ga-Labeled NOTA-EGFRvIII Aptamer in EGFRvIII-Positive Glioblastoma Xenografted Model. Pharmaceutics 2024; 16(6): 814 doi: 10.3390/pharmaceutics16060814
|
| 29 |
Gabriel Gallo-Oller, Marianna Di Scala, Fernando Aranda, Javier Dotor. Tumor Immunology and Immunotherapy – Integrated Methods Part B. Methods in Enzymology 2020; 636: 129 doi: 10.1016/bs.mie.2019.06.008
|
| 30 |
Silvia Mara Baez Rodriguez, Georgiana-Adeline Staicu, Ani-Simona Sevastre, Carina Baloi, Vasile Ciubotaru, Anica Dricu, Ligia Gabriela Tataranu. Glioblastoma Stem Cells—Useful Tools in the Battle against Cancer. International Journal of Molecular Sciences 2022; 23(9): 4602 doi: 10.3390/ijms23094602
|
| 31 |
Massimo Nabissi, Maria Beatrice Morelli, Consuelo Amantini, Sonia Liberati, Matteo Santoni, Lucia Ricci‐Vitiani, Roberto Pallini, Giorgio Santoni. Cannabidiol stimulates Aml‐1a‐dependent glial differentiation and inhibits glioma stem‐like cells proliferation by inducing autophagy in a TRPV2‐dependent manner. International Journal of Cancer 2015; 137(8): 1855 doi: 10.1002/ijc.29573
|
| 32 |
Amy Wahba, Barbara H. Rath, Kheem Bisht, Kevin Camphausen, Philip J. Tofilon. Polysome Profiling Links Translational Control to the Radioresponse of Glioblastoma Stem-like Cells. Cancer Research 2016; 76(10): 3078 doi: 10.1158/0008-5472.CAN-15-3050
|
| 33 |
N. Sumru Bayin, Dimitris G. Placantonakis. Glioblastoma. Methods in Molecular Biology 2018; 1741: 91 doi: 10.1007/978-1-4939-7659-1_7
|
| 34 |
Nasser M. Alorfi, Ahmed M. Ashour, Adnan S. Alharbi, Fahad S. Alshehri. Targeting inflammation in glioblastoma: An updated review from pathophysiology to novel therapeutic approaches. Medicine 2024; 103(21): e38245 doi: 10.1097/MD.0000000000038245
|
| 35 |
Anna Konstorum, Thomas Hillen, John Lowengrub. Feedback Regulation in a Cancer Stem Cell Model can Cause an Allee Effect. Bulletin of Mathematical Biology 2016; 78(4): 754 doi: 10.1007/s11538-016-0161-5
|
| 36 |
Uzma Hasan, Eerappa Rajakumara, Jyotsnendu Giri. Reversal of Multidrug Resistance by the Synergistic Effect of Reversan and Hyperthermia to Potentiate the Chemotherapeutic Response of Doxorubicin in Glioblastoma and Glioblastoma Stem Cells. ACS Applied Bio Materials 2023; 6(12): 5399 doi: 10.1021/acsabm.3c00644
|
| 37 |
Naiyan Wen, Baofeng Guo, Hongwu Zheng, Libo Xu, Hang Liang, Qian Wang, Ding Wang, Xuyang Chen, Shengnan Zhang, Yang Li, Ling Zhang. Bromodomain inhibitor jq1 induces cell cycle arrest and apoptosis of glioma stem cells through the VEGF/PI3K/AKT signaling pathway. International Journal of Oncology 2019; doi: 10.3892/ijo.2019.4863
|
| 38 |
Ahmad R. Safa, Mohammad Reza Saadatzadeh, Aaron A. Cohen-Gadol, Karen E. Pollok, Khadijeh Bijangi-Vishehsaraei. Glioblastoma stem cells (GSCs) epigenetic plasticity and interconversion between differentiated non-GSCs and GSCs. Genes & Diseases 2015; 2(2): 152 doi: 10.1016/j.gendis.2015.02.001
|
| 39 |
Ornella Ursini, Maddalena Grieco, Carla Sappino, Agostina Lina Capodilupo, Sara Maria Giannitelli, Emanuele Mauri, Alessio Bucciarelli, Chiara Coricciati, Valeria de Turris, Giuseppe Gigli, Lorenzo Moroni, Barbara Cortese. Modulation of Methacrylated Hyaluronic Acid Hydrogels Enables Their Use as 3D Cultured Model. Gels 2023; 9(10): 801 doi: 10.3390/gels9100801
|
| 40 |
Anh Nhat Tran, Kiera Walker, David G Harrison, Wei Chen, James Mobley, Lauren Hocevar, James R Hackney, Randee S Sedaka, Jennifer S Pollock, Matthew S Goldberg, Dolores Hambardzumyan, Sara J Cooper, Yancey Gillespie, Anita B Hjelmeland. Reactive species balance via GTP cyclohydrolase I regulates glioblastoma growth and tumor initiating cell maintenance. Neuro-Oncology 2018; 20(8): 1055 doi: 10.1093/neuonc/noy012
|
| 41 |
Gabriele Stephan, Niklas Ravn-Boess, Dimitris G Placantonakis. Adhesion G protein-coupled receptors in glioblastoma. Neuro-Oncology Advances 2021; 3(1) doi: 10.1093/noajnl/vdab046
|
| 42 |
Tomas Fiedler, Madlen Strauss, Silvio Hering, Ulrike Redanz, Doreen William, Yvonne Rosche, Carl Friedrich Classen, Bernd Kreikemeyer, Michael Linnebacher, Claudia Maletzki. Arginine deprivation by arginine deiminase ofStreptococcus pyogenescontrols primary glioblastoma growthin vitroandin vivo. Cancer Biology & Therapy 2015; 16(7): 1047 doi: 10.1080/15384047.2015.1026478
|
| 43 |
Xin Mei, Yin-Sheng Chen, Fu-Rong Chen, Shao-Yan Xi, Zhong-Ping Chen. Glioblastoma stem cell differentiation into endothelial cells evidenced through live-cell imaging. Neuro-Oncology 2017; 19(8): 1109 doi: 10.1093/neuonc/nox016
|
| 44 |
Joshua D. Frenster, Julio F. Inocencio, Zhongye Xu, Joravar Dhaliwal, Abdulhakeem Alghamdi, David Zagzag, N. Sumru Bayin, Dimitris G. Placantonakis. GPR133 Promotes Glioblastoma Growth in Hypoxia. Neurosurgery 2017; 64(CN_suppl_1): 177 doi: 10.1093/neuros/nyx227
|
| 45 |
Jee-Wei E. Chen, Sara Pedron, Peter Shyu, Yuhang Hu, Jann N. Sarkaria, Brendan A. C. Harley. Influence of Hyaluronic Acid Transitions in Tumor Microenvironment on Glioblastoma Malignancy and Invasive Behavior. Frontiers in Materials 2018; 5 doi: 10.3389/fmats.2018.00039
|
| 46 |
Michiya Sugimori, Yumiko Hayakawa, Masaki Koh, Tomohide Hayashi, Ryoi Tamura, Satoshi Kuroda. Targeting the T-Lak cell originated protein kinase by OTS964 shrinks the size of power-law coded heterogeneous glioma stem cell populations. Oncotarget 2018; 9(3): 3043 doi: 10.18632/oncotarget.23077
|
| 47 |
Claudia Capdevila, Lucía Rodríguez Vázquez, Joaquín Martí. Glioblastoma Multiforme and Adult Neurogenesis in the Ventricular‐Subventricular Zone: A Review. Journal of Cellular Physiology 2017; 232(7): 1596 doi: 10.1002/jcp.25502
|
| 48 |
Cigir Biray Avci, Cansu Caliskan Kurt, Burcu Erbaykent Tepedelen, Ozgun Ozalp, Bakiye Goker, Zeynep Mutlu, Yavuz Dodurga, Levent Elmas, Cumhur Gunduz. Zoledronic acid induces apoptosis via stimulating the expressions of ERN1, TLR2, and IRF5 genes in glioma cells. Tumor Biology 2016; 37(5): 6673 doi: 10.1007/s13277-015-4519-3
|
| 49 |
Rasime Kalkan. Therapeutic Potential of Glioblastoma Stem Cells. MOJ Cell Science & Report 2015; 2(2) doi: 10.15406/mojcsr.2015.02.00024
|
| 50 |
Kelly E. Sullivan, Kathy Rojas, Richard A. Cerione, Ichiro Nakano, Kristin F. Wilson. The stem cell/cancer stem cell marker ALDH1A3 regulates the expression of the survival factor tissue transglutaminase, in mesenchymal glioma stem cells. Oncotarget 2017; 8(14): 22325 doi: 10.18632/oncotarget.16479
|